Researchers have suggested that Amlodipine, a 4 pence-a-day cheap blood pressure capsule, could potentially help in beating vascular dementia that results from problems with the blood supply to the brain.
To test their hypothesis, scientists at the Queen's University Belfast will be holding a two-year 2.25 million-pound trial of the drug on almost 600 dementia patients, the Daily Express reported.
Previous smaller-scale studies have reported that blood pressure drugs help lower the risk of dementia, but the new study will specifically test the effects of Amlodipine.
In the study, researchers will examine if a 10mg daily dose can prevent the disease pro-gressing and improve memory by protecting brain cells with improved blood supply.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
